Immune thrombocytopenic purpura caused by immune checkpoint inhibitors for uveal malignant melanoma

J Dermatol. 2023 Sep;50(9):e292-e294. doi: 10.1111/1346-8138.16800. Epub 2023 Apr 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Melanoma* / drug therapy
  • Melanoma* / pathology
  • Purpura, Thrombocytopenic, Idiopathic* / chemically induced
  • Purpura, Thrombocytopenic, Idiopathic* / drug therapy
  • Uveal Neoplasms* / drug therapy

Substances

  • Immune Checkpoint Inhibitors

Supplementary concepts

  • Uveal melanoma